KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Astrana Health (ASTH) over the last 16 years, with Q1 2025 value amounting to -$1.1 million.

  • Astrana Health's Other Working Capital Changes rose 6464.48% to -$1.1 million in Q1 2025 from the same period last year, while for Mar 2025 it was $10.9 million, marking a year-over-year increase of 24171.34%. This contributed to the annual value of $8.9 million for FY2024, which is 23297.87% up from last year.
  • Astrana Health's Other Working Capital Changes amounted to -$1.1 million in Q1 2025, which was up 6464.48% from $12.5 million recorded in Q4 2024.
  • Astrana Health's Other Working Capital Changes' 5-year high stood at $12.5 million during Q4 2024, with a 5-year trough of -$7.1 million in Q4 2022.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$1.1 million (2025), whereas its average is -$355823.5.
  • In the last 5 years, Astrana Health's Other Working Capital Changes tumbled by 1650000.0% in 2021 and then surged by 95579.16% in 2024.
  • Over the past 5 years, Astrana Health's Other Working Capital Changes (Quarter) stood at -$687000.0 in 2021, then tumbled by 928.09% to -$7.1 million in 2022, then soared by 79.34% to -$1.5 million in 2023, then surged by 955.79% to $12.5 million in 2024, then crashed by 108.73% to -$1.1 million in 2025.
  • Its Other Working Capital Changes was -$1.1 million in Q1 2025, compared to $12.5 million in Q4 2024 and -$1.2 million in Q3 2024.